ID   Bowes/sf
AC   CVCL_A0LF
SY   Bowes/serum-free
DR   Wikidata; Q123030821
RX   CelloPub=CLPUB00745;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3317 ! HMCB
SX   Female
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   CelloPub=CLPUB00745;
RA   Harris N.S.;
RT   "Characterization of a polypeptide factor that inhibits the growth of
RT   a human breast cancer line in vitro.";
RL   Thesis MD (1988), University of Cape Town, South Africa.
//